Literature DB >> 18072149

Case files of the Children's Hospital of Michigan Regional Poison Control Center: the use of carnitine for the management of acute valproic acid toxicity.

Abhishek Katiyar1, Cynthia Aaron.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18072149      PMCID： PMC3550065          DOI： 10.1007/bf03160923

Source DB:  PubMed          Journal:  J Med Toxicol        ISSN： 1556-9039


× No keyword cloud information.
  89 in total

1.  Serum carnitine during valproic acid therapy.

Authors:  M C Laub; I Paetzke-Brunner; G Jaeger
Journal:  Epilepsia       Date:  1986 Sep-Oct       Impact factor: 5.864

2.  Sodium valproate, but not ethosuximide, produces use- and voltage-dependent limitation of high frequency repetitive firing of action potentials of mouse central neurons in cell culture.

Authors:  M J McLean; R L Macdonald
Journal:  J Pharmacol Exp Ther       Date:  1986-06       Impact factor: 4.030

3.  Valproate hepatotoxicity.

Authors:  D Scheffner; S König
Journal:  Lancet       Date:  1987-02-14       Impact factor: 79.321

4.  Valproate-induced inhibition of urea synthesis and hyperammonaemia in healthy subjects.

Authors:  M Hjelm; V Oberholzer; J Seakins; S Thomas; J D Kay
Journal:  Lancet       Date:  1986-10-11       Impact factor: 79.321

5.  Fatal liver failure in children on valproate.

Authors:  D Scheffner
Journal:  Lancet       Date:  1986-08-30       Impact factor: 79.321

6.  Cytochrome P-450--catalyzed formation of delta 4-VPA, a toxic metabolite of valproic acid.

Authors:  A E Rettie; A W Rettenmeier; W N Howald; T A Baillie
Journal:  Science       Date:  1987-02-20       Impact factor: 47.728

Review 7.  Valproic acid and the liver.

Authors:  D Cotariu; J L Zaidman
Journal:  Clin Chem       Date:  1988-05       Impact factor: 8.327

8.  Sodium valproate decreases synaptic potentiation and epileptiform activity in hippocampus.

Authors:  W H Griffith; L Taylor
Journal:  Brain Res       Date:  1988-11-22       Impact factor: 3.252

9.  Valproic acid hepatic fatalities. II. US experience since 1984.

Authors:  F E Dreifuss; D H Langer; K A Moline; J E Maxwell
Journal:  Neurology       Date:  1989-02       Impact factor: 9.910

10.  Pharmacokinetics of bolus intravenous and oral doses of L-carnitine in healthy subjects.

Authors:  P Harper; C E Elwin; G Cederblad
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953
View more
  2 in total

1.  Favorable results after conservative management of 316 valproate intoxicated patients.

Authors:  Shahin Shadnia; Hasan Amiri; Hossein Hassanian-Moghaddam; Mahdi Rezai; Zohreh Vasei; Nillofar Ghodrati; Nasim Zamani
Journal:  J Res Med Sci       Date:  2015-07       Impact factor: 1.852

Review 2.  Drugs and pharmaceuticals: management of intoxication and antidotes.

Authors:  Silas W Smith
Journal:  EXS       Date:  2010
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.